Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
J&J to offload orthopedics unit in $20B deal to Apollo: report
J&J is nearing a $20 billion deal to sell its unwanted hips-and-knees business, DePuy Synthes, to private equity firm Apollo Equity Management.
Ben Adams
Sep 14, 2026 8:40am
Abbott garners FDA nod for its TactiFlex catheter to treat AFib
Sep 9, 2026 8:09am
Boston Scientific cyberattack likely to hit financial results
Sep 8, 2026 11:44am
FDA says Boston Scientific recalls spinal cord implant
Sep 8, 2026 8:14am
Medtronic recalls reflux device amid 184 serious injuries
Sep 1, 2026 9:41am
Novocure hit by cyberattack
Sep 1, 2026 9:15am
